Stocks to Watch: Affinity Bancshares, Sangamo Therapeutics, CompoSecure

Dow Jones
2024-12-31
 

By Connor Hart

 

Affinity Bancshares will terminate a deal under which it would have been acquired by Atlanta Postal Credit Union. The companies said their boards agreed to call off the deal following discussion between the credit union and regulatory agencies. The all-cash acquisition offer was first made in May. Shares fall 17%, to $18.09, in after-hours trading.

Sangamo Therapeutics will end its gene therapy deal with Pfizer. The biotechnology company said its agreement with the pharmaceutical company on gene therapy for hemophilia A will end effective April 21, 2025. Pfizer said it no longer plans to submit the treatment for approval or try to sell it, according to Sangamo. Shares plummet 54%, to $1.08, in postmarket trading.

CompoSecure will spin off Resolute Holdings Management, a move which will see the investment team at CompoSecure and its associated costs move to Resolute. CompoSecure Executive Chairman David Cote will serve as Resolute's executive chairman, while CompoSecure director Tom Knott will become CEO. Resolute is expected to trade on the Nasdaq under the ticker RHLD, and is expected to have limited profitability in fiscal year 2025, according to CompoSecure. Shares rise 8%, to $16.92, in after-hours trading.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

December 30, 2024 18:27 ET (23:27 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10